269 related articles for article (PubMed ID: 29457868)
1. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
[TBL] [Abstract][Full Text] [Related]
2. Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process.
Eakle R; Mutanha N; Mbogua J; Sibanyoni M; Bourne A; Gomez G; Venter F; Rees H
BMJ Open; 2018 Jun; 8(6):e019292. PubMed ID: 29903784
[TBL] [Abstract][Full Text] [Related]
3. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
4. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
[TBL] [Abstract][Full Text] [Related]
6. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
Makhakhe NF; Sliep Y; Meyer-Weitz A
Front Public Health; 2022; 10():691729. PubMed ID: 35784260
[TBL] [Abstract][Full Text] [Related]
7. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.
Stoebenau K; Muchanga G; Ahmad SS; Bwalya C; Mwale M; Toussaint S; Maambo C; Peters CJ; Baumhart C; Mwango LK; Lavoie MC; Claassen CW
BMC Public Health; 2024 Jun; 24(1):1617. PubMed ID: 38886691
[TBL] [Abstract][Full Text] [Related]
9. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
Cholo FA; Dada S; Martin CE; Mullick S
J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
[TBL] [Abstract][Full Text] [Related]
10. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
Atujuna M; Newman PA; Wallace M; Eluhu M; Rubincam C; Brown B; Bekker LG
PLoS One; 2018; 13(2):e0191251. PubMed ID: 29420549
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
[TBL] [Abstract][Full Text] [Related]
12. Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India.
Reza-Paul S; Lazarus L; Doshi M; Hafeez Ur Rahman S; Ramaiah M; Maiya R; Ms V; Venukumar KT; Sundararaman S; Becker M; Moses S; Lorway R
PLoS One; 2016; 11(11):e0166889. PubMed ID: 27880833
[TBL] [Abstract][Full Text] [Related]
13. "The Drug Will Help Protect My Tomorrow": Perceptions of Integrating PrEP into HIV Prevention Behaviors Among Female Sex Workers in Lilongwe, Malawi.
Shea J; Bula A; Dunda W; Hosseinipour MC; Golin CE; Hoffman IF; Miller WC; Go VF; Lungu T; Lancaster KE
AIDS Educ Prev; 2019 Oct; 31(5):421-432. PubMed ID: 31550194
[TBL] [Abstract][Full Text] [Related]
14. Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study.
Mpunga E; Persaud N; Akolo C; Boyee D; Kamanga G; Trapence G; Chilongozi D; Ruberintwari M; Masankha Banda L
JMIR Public Health Surveill; 2021 Oct; 7(10):e26177. PubMed ID: 34228627
[TBL] [Abstract][Full Text] [Related]
15. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
Becquet V; Nouaman M; Plazy M; Masumbuko JM; Anoma C; Kouame S; Danel C; Eholie SP; Larmarange J;
BMJ Open; 2020 Jan; 10(1):e028508. PubMed ID: 31919122
[TBL] [Abstract][Full Text] [Related]
16. A qualitative assessment in acceptability and barriers to use pre-exposure prophylaxis (PrEP) among men who have sex with men: implications for service delivery in Vietnam.
Nguyen LH; Nguyen HLT; Tran BX; Larsson M; Rocha LEC; Thorson A; Strömdahl S
BMC Infect Dis; 2021 May; 21(1):472. PubMed ID: 34030652
[TBL] [Abstract][Full Text] [Related]
17. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
[TBL] [Abstract][Full Text] [Related]
18. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
Gill K; Johnson L; Dietrich J; Myer L; Marcus R; Wallace M; Pidwell T; Mendel E; Fynn L; Jones K; Wiesner L; Slack C; Strode A; Spiegel H; Hosek S; Rooney J; Gray G; Bekker LG
Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
[TBL] [Abstract][Full Text] [Related]
20. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
